Abstract
The 2017 International Congress on Schizophrenia Research, held in San Diego, California (March 24-28, 2017), attracted over 900 attendees from 34 countries. With the gracious assistance of Congress president James Meador-Woodruff, we bring you the following reports on the prospects for new drugs to treat schizophrenia.
MeSH terms
-
Antipsychotic Agents / therapeutic use*
-
Benzophenones / therapeutic use
-
Biomedical Research
-
Catechol O-Methyltransferase Inhibitors / therapeutic use*
-
Clinical Trials as Topic
-
Clozapine / therapeutic use
-
Cognitive Dysfunction / drug therapy*
-
Cognitive Dysfunction / psychology
-
Drug Discovery
-
Fatty Acids, Omega-3 / therapeutic use*
-
Humans
-
Nitrophenols / therapeutic use
-
Piperazines / therapeutic use
-
Pregnenolone / therapeutic use
-
Schizophrenia / drug therapy*
-
Schizophrenic Psychology*
-
Sodium Channel Blockers / therapeutic use*
-
Tolcapone
Substances
-
Antipsychotic Agents
-
Benzophenones
-
Catechol O-Methyltransferase Inhibitors
-
Fatty Acids, Omega-3
-
Nitrophenols
-
Piperazines
-
Sodium Channel Blockers
-
Pregnenolone
-
Tolcapone
-
cariprazine
-
Clozapine